Verve Therapeutics, Inc. Stock News

With US stock futures trading lower this morning on Friday, some of the stocks that may grab investor focus today are as follows: Hologic, Inc. (NASDAQ: HOLX) authorized a stock buyback program of u

Cathie Wood-led Ark Investment Management on Friday raised its stake in clinical stage genetics medicine company Verve Therapeutics Inc (NASDAQ: VERV) via two of its exchange-traded funds. Together, t

Cathie Wood-led Ark Investment Management on Friday raised its stake in clinical stage genetics medicine company Verve Therapeutics Inc (NASDAQ: VERV) via two of its exchange-traded funds.

Exchange-traded fund (ETF) manager Cathie Wood made headlines this week after she announced that she would cede control of her role as portfolio manager for the 3D Printing ETF (BATS: PRNT ) and the�

CAMBRIDGE, Mass., Sept. 22, 2022 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gen

The founder and CEO of ARK Investment Management is buying up drugmaker stocks like they're going out of style.

CAMBRIDGE, Mass., Sept. 22, 2022 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene

CAMBRIDGE, Mass., Sept. 21, 2022 (GLOBE NEWSWIRE) -- Verve Therapeutics, Inc., a clinical-stage biotechnology company pioneering a new approach to the care of cardiovascular disease with single-cour

ARKG component added to flagship fund. Meaningful position would top 7% of outstanding shares.

It's been a difficult year for Cathie Wood stocks and exchange-traded funds, as the ARK Innovation ETF (NYSEARCA: ARKK ) has lost over 50% of its market capitalization. The losses have been driven by

U.S. stocks closed lower with the Nasdaq Composite dropping over 100 points on Friday. Here is the list of some big stocks recording losses in the previous session. Getty Images Holdings, Inc. (NYSE:

Gainers Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares jumped 53% to close at $0.58 on Friday. Applied Optoelectronics, Inc. (NASDAQ: AAOI) shares climbed 50.4% to settle at $3.76 on Friday after

Gainers Kensington Capital Acquisition Corp. IV (NYSE: AMPX) jumped 35.4% to $13.54 after gaining 11% on Thursday. Applied Optoelectronics, Inc. (NASDAQ: AAOI) shares jumped 32.4% to $3.31 after the

Glaukos Corporation (NYSE: GKOS) gained 17.3% to $56.40 after the company announced topline data for both Phase 3 pivotal trials of iDose TR that successfully achieved its pre-specified primary effica

The biotech's long-winded rally continued this week.